Question

A kidney cancer drug delays cancer progression

A kidney cancer drug delays cancer progression

Homework Answers

Answer #1

Please don't hesitate to give a "thumbs up" for the answer in case you're satisfied with the answer

The question is : A kidney cancer drug delays cancer progression for six months, with no known side effects. An estimated treatment cost is $54,000. What is the cost per Quality Adjusted Life Year (QALY)?

If yes, then to take out the QALY just divide the treatment cost by the number of years its going to take care of.

Here, treatment cost = $54,000

time duration = 6 months = .5 years

So, QALY = 54000 / (.5) = $108,000

Answer: The QALY is $108,000

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
DISCUSSION - Incidence of kidney cancer Looking at cancer data by county, a researcher found that...
DISCUSSION - Incidence of kidney cancer Looking at cancer data by county, a researcher found that a small, rural county in the Midwest had the highest rate of kidney cancer. Another small, rural county had the lowest rate of kidney cancer. Give a plausible explanation for this.
How we can prove that an oncogene can induce cancer progression?
How we can prove that an oncogene can induce cancer progression?
• Describe the three E’s to immunoediting and how they play a role in cancer progression
• Describe the three E’s to immunoediting and how they play a role in cancer progression
6.2 Give a detailed summary on how stress influence the development and progression of cancer
6.2 Give a detailed summary on how stress influence the development and progression of cancer
In colon cancer progression, the first driver mutation is commonly a mutation to the KRas gene....
In colon cancer progression, the first driver mutation is commonly a mutation to the KRas gene. True or False
Loss of heterozygosity enhances progression to carcinoma by increasing the rate of driver mutations in cancer...
Loss of heterozygosity enhances progression to carcinoma by increasing the rate of driver mutations in cancer cells. True or False
Scenario 1: Aspirin and Kidney Cancer A group of researchers were interested in studying the use...
Scenario 1: Aspirin and Kidney Cancer A group of researchers were interested in studying the use of aspiring and the incidence of kidney cancer. They designed their study and enrolled 13,987 white, affluent, and well-educated residents of a retirement community (9,621 women and 4,366 men).   3,490 men, and 6,021 women did not use aspirin upon enrollment. There were a total of 25 cases of kidney cancer that were reported after 6.5 years of follow up (15 among men, 10 among...
A researcher aimed to investigate whether there is a gender preference for kidney cancer. She collected...
A researcher aimed to investigate whether there is a gender preference for kidney cancer. She collected a random sample of 262 kidney-cancer patients including 150 males and 112 females. Help her conduct an appropriate test for her question. Assume that the significance level is 0.05. State the null and alternative hypotheses, show your computation, AND give your conclusion.
How can diet and nutrition affect cancer risk and progression, and what practical steps can I take to protect myself?
How can diet and nutrition affect cancer risk and progression, and what practical steps can I take to protect myself?
A medical lab is testing a new anticancer drug on cancer cells. The drug stock solution...
A medical lab is testing a new anticancer drug on cancer cells. The drug stock solution concentration is 1.5×10−9M, and 4.00 mL of this solution will be delivered to a dish containing 2.0×105 cancer cells in 5.00 mL of aqueous fluid. What is the ratio of drug molecules to the number of cancer cells in the dish?
ADVERTISEMENT
Need Online Homework Help?

Get Answers For Free
Most questions answered within 1 hours.

Ask a Question
ADVERTISEMENT